Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Stage

Seed VC | Alive

Total Raised

$2.05M

Last Raised

$2.05M | 3 yrs ago

About Kamui Pharma

Developer of new drugs for Inflammatory bowel disease (IBD). The company is engaged in the research and development of therapeutic drug candidate (long-chain polyphosphate) for inflammatory bowel disease.

Kamui Pharma Headquarter Location

Asahikawa Medical University 1-1-1 Higashi 2-jo, Midorigaoka

078-8510,

Japan

81 66 68 2197

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kamui Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kamui Pharma is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.